VRCA Financials

Verrica Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$5.36

Market Cap

$79.72M

P/E Ratio

-3.6

EPS

$-1.48

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$7.57M

Gross Profit

-

Operating Income

-

Net Income

$-76.58M

EPS (Diluted)

$-1.48

Balance Sheet Highlights

Total Assets

$54.13M

Total Liabilities

$63.99M

Shareholders Equity

-

Cash & Equivalents

$46.33M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-60.93M

CapEx

-

Free Cash Flow

-

Profitability Metrics

Net Margin

-1012.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is VRCA revenue?

VRCA's most recent quarterly revenue was $7.57M. Annual revenue can be calculated by summing the four most recent quarters.

Is VRCA profitable?

VRCA reported a loss of $76.58M in the most recent quarter. The net profit margin is -1012.1%.

What is VRCA market cap?

VRCA has a market capitalization of $79.72M, making it a small-cap stock.

Does VRCA have debt?

View VRCA's balance sheet for debt information.

What is VRCA cash flow?

Cash flow data is available in the full financial statements.

Explore Categories